Former President Bill Clinton says the results of a clinical trial into the efficacy of CBD in pain management are \u201cvery encouraging,\u201d and he\u2019s emphasizing the importance of exploring alternatives to opioid-based painkillers, according to a press release from the company that supplied the cannabinoid for the study.<\/p>\n
The former president, who notoriously admitted to using marijuana in his youth but denied that he inhaled, has apparently been following the progress of cannabinoid trials at NYU Langone, which relied on CBD products supplied by TR Processing (TRP), the company announced on Tuesday.<\/p>\n
\u201cThe Clinton Foundation has worked for years to reduce opioid addiction and deaths,\u201d Clinton was quoted as saying in a press release. \u201cTo succeed, we need non-addictive alternatives to pain management. The results of the trial conducted by NYU Langone, with TRP\u2019s CBD ingredient, are very encouraging and I\u2019m eager to see the results of the next round.\u201d<\/p>\n
The results of the clinical trial<\/a>, which involved 99 participants 18-75 years old who underwent rotator cuff surgery, found that the CBD tablet ORAVEXX significantly decreased post-operative pain compared to the placebo, without any serious side effects.<\/p>\n Marijuana Moment reached out to the Clinton Foundation and the former president\u2019s office for additional comment, but a representative was not immediately available.<\/p>\n The new statement on the results tracks with comments the former president reportedly made earlier this year, talking about emerging research into cannabidiol as an effective treatment that can help \u201ccombat pain.\u201d<\/a><\/p>\n At the time, the article on his remarks were deleted\u2014allegedly related to pressure from Clinton\u2019s team\u2014before being posted online again.<\/p>\n In any case, TRP also said on Tuesday that a former White House deputy drug czar, Andrea Barthwell, has joined the company\u2019s board of directors and will be leading a division of the business dedicated to developing patented therapeutics. Barthwell has been sharply criticized<\/a> by advocates over prior dismissive and misleading claims she made about medical cannabis, suggesting it amounted to snake oil before going on to assist GW Pharmaceuticals as they worked to get approval for the cannabinoid-based drug Sativex.<\/p>\n\n \u201cI am excited by TRP\u2019s focus on responsible development of cannabinoids and believe patients, physicians, and pharmaceutical companies are looking for safe and effective solutions for pain management and general health and well-being,\u201d Barthwell said in the company\u2019s press release<\/a>.<\/p>\n With respect to Clinton, his\u00a0administration opposed efforts to legalize medical cannabis and even took the extreme step of threatening<\/a>\u00a0to revoke Drug Enforcement Administration (DEA) prescribing licenses for doctors who recommended marijuana to patients in accordance with state law.<\/p>\n Also, despite pleas to reduce the racially disparate crack-cocaine sentencing disparity, the former president took no action to remediate the issue. He also rejected requests to lift a federal ban on harm reduction policies like syringe exchange programs.<\/p>\n Yet in an exit\u00a0interview<\/a> published by Rolling Stone in 2000 just before he left office, Clinton appeared to endorse cannabis reform, saying that he thinks that \u201cmost small amounts of marijuana have been decriminalized in some places, and should be.\u201d<\/p>\n Pennsylvania Governor Signs Marijuana Banking And Insurance Reform Bill Into Law<\/a><\/p>\n<\/blockquote>\n\n Photo element courtesy of Gage Skidmore<\/a>.<\/em><\/p>\n The post Bill Clinton Thinks CBD Study Shows \u2018Very Encouraging\u2019 Results In Search For Opioid Alternatives To Treat Pain, Company Says<\/a> appeared first on Marijuana Moment<\/a>.<\/p>\n
Former President Bill Clinton says the results of a clinical trial into the efficacy of CBD in pain management are \u201cvery encouraging,\u201d and he\u2019s emphasizing the importance of exploring alternatives to opioid-based painkillers, according to a press release from the company that supplied the cannabinoid for the study. The formerContinue Reading<\/a><\/span><\/p>\n","protected":false},"author":458,"featured_media":0,"comment_status":"false","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[18,81],"tags":[],"_links":{"self":[{"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/posts\/55825"}],"collection":[{"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/users\/458"}],"replies":[{"embeddable":true,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/comments?post=55825"}],"version-history":[{"count":1,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/posts\/55825\/revisions"}],"predecessor-version":[{"id":55826,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/posts\/55825\/revisions\/55826"}],"wp:attachment":[{"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/media?parent=55825"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/categories?post=55825"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/tags?post=55825"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}\n
\n
\nRead More: Bill Clinton Thinks CBD Study Shows \u2018Very Encouraging\u2019 Results In Search For Opioid Alternatives To Treat Pain, Company Says<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"